June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Blockade of transient receptor potential (TRP) channels inhibits retinal neovascularization via inhibition of calcium ion dependent signaling pathway
Author Affiliations & Notes
  • Hyun Beom Song
    Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
    Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Hyoung Oh Jun
    Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Jin Hyoung Kim
    Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Inho Jo
    Department of Molecular Medicine and Ewha Medical Research Institute, Ewha Womans University Medical School, Seoul, Republic of Korea
  • Jeong Hun Kim
    Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
    Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Hyun Beom Song, None; Hyoung Oh Jun, None; Jin Hyoung Kim, None; Inho Jo, None; Jeong Hun Kim, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5614. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyun Beom Song, Hyoung Oh Jun, Jin Hyoung Kim, Inho Jo, Jeong Hun Kim; Blockade of transient receptor potential (TRP) channels inhibits retinal neovascularization via inhibition of calcium ion dependent signaling pathway. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5614.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The aim of this study is to investigate whether blockade of transient receptor potential (TRP) channels inhibits retinal neovascularization in the mouse model of oxygen induced retinopathy.

Methods: The expressions of TRP channel isoforms on mouse retina and human renal microvascular endothelial cells (HRMECs) were evaluated by RT-PCR. The anti-angiogenic activity of TRP channel inhibitors and calcium ion chelators was evaluated by vascular endothelial growth factor (VEGF)-induced proliferation, migration and in vitro tube formation assay of HRMECs. In the mouse model of oxygen induced retinopathy, calcium ion level was evaluated by TOF-SIMS, and retinal neovascularization was evaluated after intraocular injection of TRP channel inhibitors and calcium ion chelators, whose effect on MAPK signaling pathway was evaluated by Western blot analysis.

Results: TRP channel 1, 4 and 6 were strongly expressed on mouse retina and HRMECs. TRP channel inhibitor, SKF 96365 and 2-APB, and calcium ion chelators, BAPTA, effectively suppressed VEGF-induced in vitro angiogenesis of HRMECs including proliferation, migration and tube formation, respectively. In the mouse model of oxygen induced retinopathy, calcium ion was increased at inner retina during neovascularization, and intraocular injection of TRP channel inhibitor, SKF 96365 and 2-APB, and calcium ion chelators, BAPTA, significantly inhibited retinal neovascularization, which also modulated ERK-1/2 signaling pathway.

Conclusions: Calcium ion dependent signaling pathways mediated by TRP channels are involved in retinal angiogenesis. Furthermore, inhibiting retinal neovascularization by blockade of TRP channels could be extensively applied to variable vaso-proliferative retinopathies.

Keywords: 700 retinal neovascularization • 439 calcium • 706 retinopathy of prematurity  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×